当前位置: 首页 > 期刊 > 《中外医疗》 > 2019年第25期
编号:13408863
UGT1A1基因突变对乙型肝炎慢加亚急性肝衰竭患者转归的影响(4)
http://www.100md.com 2019年9月5日 《中外医疗》 2019年第25期
     [2] Sun, L,LiMan Zhang Liang et al. Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II[J]. Medicine (Baltimore),2017,96(45): e8620.

    [3] Remco van Dijk, Andreas E, Kremer. Characterization and treatment of persistent hepatocellular secretory failure[J].Liver International,2015,35:1478-1488.

    [4] Marano M,Serafinelli J. Eltrombopag-Induced Acute Liver Failure in a Pediatric Patient: A Pharmacokinetic and Pharmacogenetic Analysis[J].Therapeutic Drug Monitoring,2018,40(4):386-388.

    [5] Luo L, An P,Jia X,et al.Genetically Regulated Bilirubin and Risk Of Non-alcoholic Fatty Liver Disease:A Mendelian Randomization Study[J].Frontiers in Genetics,2018,12(9):662.

    [6] 杨文龙,孙水林.终末期肝病模型评分与Child-Tur-cotte-Pugh 分级对非生物型人工肝治疗乙型肝炎相关性肝衰竭患者预测价值的研究[J].中华危重症医学杂志: 电子版,2016,9(1):20-27.

    [7] 陈岭岭,李谦.外周血NLR、PCT及MELD評分对慢加急(亚急)性肝衰竭近期预后的预测价值[J].天津医科大学学报,2017,23(2):151-154.

    [8] 李晓永,尚华.HBV感染失代偿期肝硬化并发慢加亚急性肝衰竭患者临床特点及预后因素分析[J].疑难病杂志,2018, 17(11):1238-1241.

    [9] 戚宇琪,郭晓霞.Gilbert综合征5例临床及遗传学分析[J].肝脏,2018,23(10):888-891.

    (收稿日期:2019-06-05), http://www.100md.com(卓海燕 范金海 姚履枫 陈立 陈阮琴 李东良)
上一页1 2 3 4